Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar Disorder

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Serge Beaulieu, Douglas Mental Health University Institute
ClinicalTrials.gov Identifier:
NCT00999765
First received: October 21, 2009
Last updated: January 30, 2012
Last verified: January 2012
  Purpose

The purpose of this study is to evaluate the feasibility and short-term efficacy of MBCT as an add-on (i.e. patients must be stable with their regular mood stabilizing medication) for the maintenance therapy of bipolar disorder.


Condition Intervention
Bipolar Disorder
Behavioral: Mindfulness-Based Cognitive Therapy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar Disorder

Resource links provided by NLM:


Further study details as provided by Douglas Mental Health University Institute:

Primary Outcome Measures:
  • number of weeks in which criteria are meet for a mood episode evaluate with the Longitudinal Interval Follow-up Evaluation (LIFE) [ Time Frame: 12 weeks (4 weeks post treatment) ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change in intensity of subsyndromal symptoms of depression on the HAM-D 29 scale [ Time Frame: 2, 4, 6, 8 and 12 weeks ] [ Designated as safety issue: No ]
  • Change in intensity of subsyndromal symptoms of depression on the MADRS scale [ Time Frame: 2, 4, 6, 8 and 12 weeks ] [ Designated as safety issue: No ]
  • Change in intensity of subsyndromal symptoms of hypomania on the YMRS scale [ Time Frame: 2, 4, 6, 8 and 12 weeks ] [ Designated as safety issue: No ]
  • Change id intensity in subsyndromal symptoms of anxiety on the HAM-A scale [ Time Frame: 2,4,6,8 and 12 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 36
Study Start Date: June 2008
Estimated Study Completion Date: December 2012
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Bipolar Disorder - stable Behavioral: Mindfulness-Based Cognitive Therapy
eight-week (two hours a week) group therapy (8-12 patients per group)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Bipolar Disorder of third-line bipolar disorders program

Criteria

Inclusion Criteria:

  • Males or females (>18 years old)
  • Bipolar disorder (as per the Structured Clinical Interview for DSM Disorders (SCID)(22)), euthymic state: Complete remission for at least four weeks ((Montgomery and Asberg Rating Scale (MADRS) ≤ 6 and item-1 (depressed mood) = 0 and no suicidal ideations (MADRS(item-10) < 4)
  • Must have had at least 3 depressive phases in the last 5 years
  • Cooperative and willing to complete all the aspects of the study and especially the 45 minutes of exercise per day
  • Must have completed a Secondary V (11th grade) education

Exclusion Criteria:

  • Other active psychiatric disorders (as per the SCID)
  • Rapid cycling
  • Bipolar disorder secondary to a medical condition or substance-induced mood disorder
  • Suicidal ideations (MADRS(item 10)>3)
  • Active i.e. unstable and/or untreated medical condition
  • Substance abuse (defined as per DSM-IV) in the last four weeks
  • CBT (No more than four sessions (ever))
  • Previous participation in a psychoeducation group within the last 6 months
  • Current other psychotherapy (more than once a month)
  • Practice of meditation (more than once a month) during the last two years
  • Practice of yoga (more than once a week) during the last year
  • Previous participation in a MBSR group
  • Electroconvulsive Therapy (ECT) within the last three months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00999765

Locations
Canada, Quebec
Douglas Mental Health University Institute
Montréal, Quebec, Canada, H4H 1R3
Sponsors and Collaborators
Douglas Mental Health University Institute
Investigators
Principal Investigator: Serge Beaulieu, Ph.D. Douglas Mental Health University Institute / McGill
  More Information

No publications provided

Responsible Party: Serge Beaulieu, Douglas Mental Health University Institute
ClinicalTrials.gov Identifier: NCT00999765     History of Changes
Other Study ID Numbers: BD-MBCT
Study First Received: October 21, 2009
Last Updated: January 30, 2012
Health Authority: Canada: Canadian Institutes of Health Research
Canada: Ethics Review Committee
Canada: Health Canada

Keywords provided by Douglas Mental Health University Institute:
Bipolar Disorder
Bipolar Depression
Mindfulness-Based Cognitive Therapy
MBCT
Maintenance
Euthymic
Efficacy
Feasibility

Additional relevant MeSH terms:
Bipolar Disorder
Affective Disorders, Psychotic
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013